---
title: 'Stock Administrator at Alamar Biosciences'
canonical: 'https://feeny.ai/job/stock-administrator-alamar-biosciences-fremont-fbytm8kd9wz6'
type: 'job'
last_seen: '2026-10-19'
---

# Stock Administrator at Alamar Biosciences

- **Company:** Alamar Biosciences
- **Location:** Fremont, CA
- **Posted:** 2026-09-23
- **Last confirmed live:** 2026-10-19
- **Apply:** https://job-boards.greenhouse.io/alamarbiosciences/jobs/6110929004

## Job description

At Alamar, we are passionate about enabling our customers to make scientific discoveries that translate into clinical outcomes and benefit patients. Our team is growing quickly as we develop innovative approaches to measure critical protein biomarkers from liquid samples that can enable the earliest possible detection of disease. We believe the next frontier in biology is enabled by measuring proteins at higher sensitivity in highly multiplexed assays at the push of a button, which is something only Alamar can do. As we build our team, we seek collaborative, driven, intellectually curious people committed to solving complex challenges. Our culture rewards accountability and cross functional teamwork because we believe this enables the kind of breakthrough thinking that will accelerate our mission.

The Stock Administrator is responsible for the accurate administration, accounting support, and compliance oversight of Alamar’s equity compensation programs. Reporting to the VP, Corporate Controller, this role is critical to maintaining equity data integrity, supporting financial reporting and audits, and ensuring compliance with public‑company requirements while providing a positive employee equity experience.

## Responsibilities

Equity Administration & Controls

- Administer all equity compensation programs (stock options, RSUs, and ESPP) in accordance with equity plans, grant agreements, and company policies
- Process equity transactions in the Equity Edge equity administration system (E*TRADE), including grants, vesting, exercises, cancellations, and forfeitures
- Maintain accurate equity records and ensure proper documentation to support SOX controls and audit requirements
- Liaise with Computershare and reconcile transfer agent data as appropriate.

Financial Reporting & Public Company Support

- Partner closely with the Controller’s team on equity‑related accounting, reporting, and reconciliations for monthly, quarterly, and annual close
- Prepare equity schedules and roll forwards to support financial statements, footnote disclosures, and audit requests
- Support SEC‑related filings and disclosures (e.g., proxy equity tables, share‑based compensation support, Forms 4 coordination)
- Assist with valuation inputs and tracking related to ASC 718

Cross‑Functional Collaboration

- Coordinate with Payroll on taxable equity events, withholdings, and reporting
- Partner with Legal on equity plan administration, insider compliance, and documentation
- Work with HR and Talent teams to incorporate equity compensation as a critical component of total compensation and execute new hire, promotion, refresh, and off‑cycle equity grants

Employee & Executive Support

- Serve as a knowledgeable point of contact for employee and executive equity questions, including vesting, exercises, and termination treatment
- Support senior leadership and Board‑level equity reporting as needed
- Help develop clear, employee‑friendly equity communications and reference materials

Process Improvement & Scale

- Identify and implement process improvements to strengthen controls, efficiency, and scalability in a post‑IPO environment
- Support equity system enhancements, integrations, and vendor management

## Qualifications

Required

- 3–6+ years of experience in stock administration, equity compensation, or related finance/HR role
- CEP or equivalent credential
- Experience supporting equity administration in a public company
- Strong understanding of stock options, RSUs and ESPP offerings; familiarity with ASC 718 concepts
- Hands‑on experience with Equity Edge administration platform (E*TRADE)
- Exceptional attention to detail and experience handling confidential financial data
- Strong Excel skills and ability to reconcile complex equity data

## Preferred

- Experience in biotech, life sciences, or high‑growth public companies
- Exposure to SOX, audits, and SEC reporting processes

## Key Competencies

- Financial accuracy and strong internal controls mindset
- Ability to partner effectively with Finance, Legal, HR, and Payroll
- Clear communication of complex equity topics to non‑experts
- Comfortable operating in a fast‑paced, post‑IPO environment

The base salary range for this full-time position is $160,000 - $180,000 + bonus + equity + benefits. Our salary ranges are determined by work location, job-related skills, experience, and relevant education or training. The ranges displayed on each job posting reflect the minimum and maximum target for new hire salaries but are subject to change if the leveling of the role is adjusted. Your recruiter can share more about the specific salary range during the hiring process. Please Note - We participate in E-Verify to confirm authorization to work in the United States.

## About Alamar Biosciences

## Company Overview
- **One-liner**: Alamar Biosciences develops a precision proteomics platform that enables ultra-high sensitivity, multiplex protein analysis from minimal sample volumes to power the earliest detection of disease.
- **Entity Type**: Public (IPO on April 17, 2026; Market Cap: $1.37B as of search date)
- **Headquarters**: Fremont, California, USA
- **Founded**: 2018
- **Founders**: Yuling Luo, PhD (Co-founder, CEO and Chair), Yiyuan Yin, PhD (Co-founder, COO and Director), and Xiao-Jun Ma, PhD (CTO)

## Core Business
- **Primary industry**: Precision proteomics / Biotechnology / Diagnostics
- **Target customers**: B2B – Academic researchers, pharmaceutical companies, clinical diagnostic labs, and biomarker discovery groups.
- **Mission or purpose**: “Powering precision proteomics to enable the earliest detection of disease.”

## Products & Services
- **NULISA Chemistry & Consumables**: A proprietary assay technology (Nucleic Acid Linked Immuno-Sandwich Assay) that combines ultra-high sensitivity with high specificity, capable of analyzing hundreds of protein biomarkers in a single 10 µL biofluid sample. Available in pre-configured panels (e.g., NULISAseq™ Neuro 220 Panel for neurological disease research).
- **ARGO System**: An all-in-one automated instrument with onboard qPCR that runs NULISA assays from sample to result, enabling walk-away automation for both single-plex and multiplex biomarker analysis.
- **Alamar Software**: A comprehensive data analysis and visualization platform that integrates with the ARGO instrument to turn raw data into actionable insights.

## Market Standing
- **Valuation/Market Cap**: $1.37 billion market cap (post-IPO, April 2026)
- **Key Metric**: Total funding raised prior to IPO: $254 million. Annual revenue not publicly disclosed.
- **Notable Investors/Partners**: Illumina Ventures, Sands Capital, T. Rowe Price, Braidwell, Alzheimer’s Disease Data Initiative, and others.
- **Growth Signals**: 
  - Successfully completed IPO in April 2026.
  - Launched NULISAseq™ Neuro 220 Panel, the company’s largest precision proteomics panel.
  - Demonstrated compatibility of home-collected fingerstick samples with ultra-high-sensitivity multiplex proteomics.
  - Filed 8 patents covering key technologies (e.g., NULISA, immunologic tests, molecular biology).

## Competitive Advantages
- **Ultra-sensitivity & specificity**: NULISA technology achieves sensitivity rivaling single-plex assays while enabling high-plex panels, addressing a key trade-off in proteomics.
- **Automation-friendly**: The ARGO system delivers a fully integrated, walk-away workflow, reducing hands-on time and variability.
- **Low sample volume**: Requires only 10 µL of biofluid, enabling studies with precious or limited samples (e.g., fingerstick blood).
- **Proven team**: Founders and senior scientists previously created RNAscope™, a widely adopted in situ hybridization technology, demonstrating a track record of successful innovation.

## Strategic Focus
- Expand the NULISA panel menu into new therapeutic areas (neurodegeneration, oncology, inflammation).
- Drive adoption of the ARGO platform in both research and clinical diagnostic settings.
- Leverage IPO proceeds to scale manufacturing, commercial team, and global sales presence (hiring for roles in EMEA, China, Japan, and the US).
- Continue R&D investments in next-generation assay chemistry and software.

## Why Work Here
- **Culture**: Emphasizes integrity, excellence, passion, respect, inclusion, and collaboration. Fosters continuous learning, out-of-the-box thinking, and risk-taking.
- **People philosophy**: “Our people are the key to success” – the company is building a high-performance team dedicated to improving human health.
- **Benefits**: Competitive compensation package includes health, dental, vision, life insurance, flexible spending plan, paid vacation, stock options, and a 401(k) plan.
- **Work location**: Based in Fremont, CA (Silicon Valley) with a state-of-the-art facility designed for biotech innovation. Some roles are remote (e.g., Inside Sales Specialist – EMEA) or field-based.
- **Growth opportunities**: As a recently public company, there is significant upside potential and the chance to shape the commercial and product trajectory of a platform technology.

## Sources
1. [alamarbio.com](https://alamarbio.com/) – Official company website
2. [alamarbio.com/about-us](https://alamarbio.com/about-us/) – About page, founders, mission, location
3. [alamarbio.com/company/careers](https://alamarbio.com/company/careers/) – Careers page, culture, benefits
4. [job-boards.greenhouse.io/alamarbiosciences](http://job-boards.greenhouse.io/alamarbiosciences) – Current job openings
5. [cbinsights.com/company/alamar-biosciences](https://www.cbinsights.com/company/alamar-biosciences) – Financial data, funding, IPO date, market cap, investors, patents

## Other roles at Alamar Biosciences

- [Field Service Engineer II - US East](https://feeny.ai/job/field-service-engineer-ii-us-east-alamar-biosciences-baltimore-ma-or-f6w8vm30hj9v) — Baltimore MA OR Philadelphia, PA
- [Scientist I, Technology Development](https://feeny.ai/job/scientist-i-technology-development-alamar-biosciences-fremont-b52st1tydp43) — Fremont, CA
- [Regional Business Manager (Midwest)](https://feeny.ai/job/regional-business-manager-midwest-alamar-biosciences-detroit-q7v708x2f1w3) — Detroit, MI / Columbus, OH / Indianapolis, IN
- [Regional Business Manager (West)](https://feeny.ai/job/regional-business-manager-west-alamar-biosciences-san-francisco-m2zgb5kem5sj) — San Francisco, CA / Seattle, WA / Portland, OR
- [Regional Business Manager (Southwest)](https://feeny.ai/job/regional-business-manager-southwest-alamar-biosciences-houston-b4zc0q3yvcpm) — Houston, TX / Dallas, TX / San Antonio, TX
- [Regional Business Manager (Northeast)](https://feeny.ai/job/regional-business-manager-northeast-alamar-biosciences-boston-j4tf5m60r9sj) — Boston, MA
- [Regional Business Manager (Mid-Atlantic)](https://feeny.ai/job/regional-business-manager-mid-atlantic-alamar-biosciences-philadelphia-gfszspjtfe7g) — Philadelphia, PA
- [Area Sales Manager - US (Southeast)](https://feeny.ai/job/area-sales-manager-us-southeast-alamar-biosciences-washington-w8q3nxfkrr0m) — Washington, DC
- [Area Sales Manager - US (Northeast)](https://feeny.ai/job/area-sales-manager-us-northeast-alamar-biosciences-new-york-rvah9s01ncyq) — New York, NY
- [Senior Manager, Quality Systems](https://feeny.ai/job/senior-manager-quality-systems-alamar-biosciences-fremont-13he19fqs4vt) — Fremont, CA